Physician profile
Sumit Bhatla
NPI 1104823137
$893.42
in general payments reported to CMS, 2019-2025
10 companies · $62.71 in 2025
The $62.71 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.50 · 2020: $28.10 · 2021: $240 · 2022: $141 · 2023: $360 · 2024: $34.64 · 2025: $62.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $279.24 | 2021-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Advanced Critical Devices, INC. | $256.99 | 2021-2024 | Vacular Products |
| Philips North America LLC | $86.81 | 2022-2025 | Intrasight Mobile |
| Medtronic, INC. | $81.89 | 2021-2022 | |
| Angiodynamics, INC. | $52.40 | 2021 | |
| Abbott Laboratories | $51.25 | 2023-2025 | Viewmate |
| Stryker Corporation | $28.10 | 2020 | |
| Bard Peripheral Vascular, INC. | $27.50 | 2019 | |
| Becton, Dickinson and Company | $17.14 | 2025 | Pleurx |
| Astrazeneca Pharmaceuticals LP | $12.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumit Bhatla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.